Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276184 · ClinicalTrials.gov registry record · NA
Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil
A NA study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01276184 is a NA study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 22 participants.
The verdict
NCT01276184, a NA study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Human papillomavirus (HPV) is the most common sexually transmitted disease among adolescent females in the United States. Our primary objective is to determine if Short Message Service (SMS) text message reminders increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care in an outpatient clinic setting. Secondary objectives of this study are: 1) to demonstrate the feasibility of using SMS text message reminders to increase adherence with Gardasil vaccination; and 2) to assess satisfaction and acceptability of text message reminders compared to telephone reminders among women who receive the text message arm of the intervention. The investigators hypothesize that receiving SMS text message reminders will increase adherence to the recommended 3 dose schedule for Gardasil compared to usual care.
Interventions
- BEHAVIORAL SMS Text Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01276184
The ClinicalTrials.gov registry entry for NCT01276184 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SMS Text Message is the first listed.
NCT01276184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01276184 about?
NCT01276184 is a clinical study titled "Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil". Human papillomavirus (HPV) is the most common sexually transmitted disease among adolescent females in the United States. Our primary objective is to determine if Short Message Service (SMS) text message reminders increase adherence to the recommended 3 dose schedule for Gardasil compared to usual c...
What is the current status of trial NCT01276184?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2011-01. Estimated completion is 2016-06-15.
What interventions are being tested in trial NCT01276184?
The interventions under investigation include: SMS Text Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT01276184?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.